California State Teachers Retirement System Lowers Stake in Orthofix International NV (OFIX)
California State Teachers Retirement System lowered its stake in Orthofix International NV (NASDAQ:OFIX) by 8.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,712 shares of the medical device company’s stock after selling 3,207 shares during the period. California State Teachers Retirement System owned about 0.20% of Orthofix International NV worth $1,557,000 as of its most recent filing with the SEC.
A number of other large investors have also recently bought and sold shares of the company. Acadian Asset Management LLC raised its stake in Orthofix International NV by 90.6% in the first quarter. Acadian Asset Management LLC now owns 527,659 shares of the medical device company’s stock worth $21,906,000 after buying an additional 250,778 shares during the period. Norges Bank bought a new stake in Orthofix International NV during the fourth quarter worth about $9,643,000. Renaissance Technologies LLC raised its stake in Orthofix International NV by 78.7% in the first quarter. Renaissance Technologies LLC now owns 456,379 shares of the medical device company’s stock worth $18,949,000 after buying an additional 201,020 shares during the period. Goldman Sachs Group Inc. raised its stake in Orthofix International NV by 59.7% in the first quarter. Goldman Sachs Group Inc. now owns 65,550 shares of the medical device company’s stock worth $2,721,000 after buying an additional 24,513 shares during the period. Finally, Bogle Investment Management L P DE raised its stake in Orthofix International NV by 37.6% in the first quarter. Bogle Investment Management L P DE now owns 81,833 shares of the medical device company’s stock worth $3,397,000 after buying an additional 22,365 shares during the period. Institutional investors own 92.41% of the company’s stock.
Orthofix International NV (NASDAQ:OFIX) traded down 1.26% on Monday, reaching $43.92. The company had a trading volume of 110,921 shares. Orthofix International NV has a 52-week low of $32.25 and a 52-week high of $48.25. The stock’s market capitalization is $796.01 million. The stock has a 50 day moving average price of $43.90 and a 200 day moving average price of $43.68.
Orthofix International NV (NASDAQ:OFIX) last posted its earnings results on Monday, August 1st. The medical device company reported $0.41 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.33 by $0.08. The business had revenue of $104.10 million for the quarter, compared to analyst estimates of $102.40 million. Orthofix International NV had a negative net margin of 0.37% and a positive return on equity of 8.50%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.36 EPS. Analysts expect that Orthofix International NV will post $1.41 EPS for the current year.
A number of research analysts recently commented on OFIX shares. Zacks Investment Research upgraded Orthofix International NV from a “hold” rating to a “buy” rating and set a $47.00 price objective on the stock in a report on Wednesday, June 29th. TheStreet cut Orthofix International NV from a “buy” rating to a “hold” rating in a report on Wednesday, August 3rd.
In other Orthofix International NV news, insider Michael Finegan sold 25,000 shares of the business’s stock in a transaction on Thursday, September 1st. The shares were sold at an average price of $45.16, for a total value of $1,129,000.00. Following the transaction, the insider now owns 51,670 shares in the company, valued at approximately $2,333,417.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 5.10% of the stock is currently owned by company insiders.
Orthofix International NV Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International NV (NASDAQ:OFIX).
Receive News & Ratings for Orthofix International NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International NV and related companies with Analyst Ratings Network's FREE daily email newsletter.